Overview

A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
Studies in animals suggest that inhaled budesonide may prevent the occurrence of lung cancer. We conducted a clinical trial to determine the effects of inhaled budesonide in smokers who had precancerous lesions in the breathing tubes (i.e. bronchial dysplasia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of British Columbia
Collaborator:
National Cancer Institute (NCI)
Treatments:
Budesonide